HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026

Findings demonstrate HERV-K is required for senescence-associated inflammation in metabolically challenged cells and is reactivated in plasma of subjects living with obesity COPENHAGEN, Denmark and NEW YORK, July 15, 2026 /PRNewswire/ -- HERVolution Therapeutics ApS, a biotechnology...